Rybrevant
Brand Name: Rybrevant
Generic Name: Amivantamab
Active
Registration Number
BR-1439
Dosage Form
Concentrate For Solution For Infusion (IV)
Issuance Date
February 17, 2023
Expiry Date
February 17, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength350 mg/7 mL (50mg/mL)
PackagingType I glass vial with grey fluorotec-coated butyl rubber stopper and aluminum seal with white plastic flip-off cap (Box of 1's).
Classification
C
Classification
Prescription Drug (RX)
A
Application
Monitored Release
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
AmivantamabActive
Monograph: Amivantamab